Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 | Starlite/ChEMBL | References |
Homo sapiens | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 | Starlite/ChEMBL | References |
Homo sapiens | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 | 449 aa | 439 aa | 26.9 % |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 | 471 aa | 434 aa | 26.3 % |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 | 500 aa | 429 aa | 24.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0208 | 0.9706 | 0.9706 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0211 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0208 | 0.9706 | 0.9604 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.0211 | 1 | 0.5 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.0125 | 0.2852 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0125 | 0.2852 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0211 | 1 | 1 |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.0125 | 0.2852 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0125 | 0.2852 | 0.5 |
Schistosoma mansoni | 6-phosphofructokinase | 0.0211 | 1 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0208 | 0.9706 | 0.9706 |
Giardia lamblia | Hypothetical protein | 0.0125 | 0.2852 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0211 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0211 | 1 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0208 | 0.9706 | 0.9706 |
Onchocerca volvulus | 0.0211 | 1 | 0.5 | |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.0208 | 0.9706 | 0.9706 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0211 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Fu (ADMET) | = 0.33 % | Fraction unbound in human plasma | ChEMBL. | 25849762 |
Fu (ADMET) | = 1.64 % | Fraction unbound in mouse plasma | ChEMBL. | 25849762 |
IC50 (binding) | = 0.023 uM | Inhibition of recombinant human PFKFB3 using fructose 6 phosphate as substrate assessed as ADP generation after 1 hr by ADP Glo assay | ChEMBL. | 25849762 |
IC50 (binding) | = 0.343 uM | Inhibition of PFKFB3 in human A549 cells assessed as reduction of fructose-1,6-bisphosphate formation after 4 hrs by MS/MS analysis | ChEMBL. | 25849762 |
IC50 (binding) | = 0.384 uM | Inhibition of recombinant human PFKFB2 using fructose 6 phosphate as substrate assessed as ADP generation after 1 hr by ADP Glo assay | ChEMBL. | 25849762 |
IC50 (binding) | = 2.06 uM | Inhibition of recombinant human PFKFB1 using fructose 6 phosphate as substrate assessed as ADP generation after 1 hr by ADP Glo assay | ChEMBL. | 25849762 |
IC50 (binding) | = 5.77 uM | Inhibition of PFKFB3 in human A549 cells assessed as decrease in lactate secretion after 4 hrs | ChEMBL. | 25849762 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.